Mercator MedSystems, Inc., a medical technology company, develops catheter-guided microfluid injection systems for site-specific delivery of therapeutic agents directly across various blood vessels. The company offers Cricket and Bullfrog micro-infusion catheters, which are designed to inject therapeutic agents directly and non-systemically through blood vessel walls into deep tissues. It offers products for the treatment of blood vessel restenosis caused by inflammation after vascular injury; micro-infusion devices to infuse drugs, genes, and cells without material loss in viability or potency; inflammation and restenosis treatment for peripheral artery disease; and micro-infusion catheter for the treatment of neointimal hyperplasia associated with stenotic dialysis access failure. The company’s products are used in various therapies, such as treatments for plaque stabilization in diseased vessels, anti-tumor drugs, growth factors to stimulate cell division, and stem cell transplantation and gene therapies. Its technology also enables the commercialization of novel therapeutics for other vascular diseases, hypertension, oncology, and regenerative medicine. Mercator MedSystems, Inc. was formerly known as Endobionics, Inc. The company was founded in 1999 and is based in Emeryville, California.